Conversion and Reversion Rates of Tuberculosis Screening Assays in Patients With Rheumatic Diseases and Negative Baseline Screening Under Long-Term Biologic Treatment

BACKGROUND: To determine the conversion and reversion rates of tuberculosis (TB) screening tests (Tuberculin Skin Test-TST, Interferon Gamma Release Assay-IGRA: T-SPOT.TB) during biologic treatment in patients with rheumatic diseases and negative baseline screening. METHODS: This was a long-term, lo...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Pathog Immun
Autors principals: Thomas, Konstantinos, Hadziyannis, Emilia, Hatzara, Chrisoula, Makris, Anastasia, Tsalapaki, Christina, Lazarini, Argyro, Klavdianou, Kalliopi, Antonatou, Katerina, Koutsianas, Christos, Vassilopoulos, Dimitrios
Format: Artigo
Idioma:Inglês
Publicat: Pathogens and Immunity 2020
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7104555/
https://ncbi.nlm.nih.gov/pubmed/32258853
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.20411/pai.v5i1.349
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars